Results 31 to 40 of about 1,502,566 (303)

Harnessing the power of cell transplantation to target respiratory dysfunction following spinal cord injury. [PDF]

, 2017
The therapeutic benefit of cell transplantation has been assessed in a host of central nervous system (CNS) diseases, including disorders of the spinal cord such as traumatic spinal cord injury (SCI).
Charsar, Brittany A., Lepore, Angelo C., Urban, Mark W.   +2 more
core   +2 more sources

Chimerism after organ transplantation [PDF]

, 1997
Recent evidence suggests that passenger leukocytes migrate after organ transplantation and produce persistent chimerism, which is essential for sustained survival of the allograft.
Demetris, AJ, Fung, JJ, Murase, N, Rao, AS, Starzl, TE, Thomson, AW, Trucco, M   +6 more
core   +1 more source

Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C. [PDF]

, 2017
Background and Aims: Hepatitis C virus (HCV) cirrhosis is the leading indication for liver transplantation in the United States and recurrent HCV following liver transplantation is a major cause of allograft loss and mortality.
Aby, Elizabeth, Agopian, Vatche, Busuttil, Ronald W, French, Samuel W, Grotts, Jonathan F, Jimenez, Melissa A, Saab, Sammy   +6 more
core   +1 more source

Bordetella hinzii Meningitis in Patient with History of Kidney Transplant, Virginia, USA

Emerging Infectious Diseases, 2021
A patient in Virginia, USA, who had previously undergone multiple kidney transplantations showed signs of Bordetella hinzii bacteremia and meningitis.
Joseph Pechacek, Jillian Raybould, Megan Morales   +2 more
doaj   +1 more source

Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications [PDF]

, 2018
Background Treatment of hepatic hydrothorax (HH) generally involves sodium restriction, diuretics, and serial thoracentesis. In more advanced cases, transjugular intrahepatic portosystemic shunt and liver transplantation may be required.
Bosslet, Gabriel, Diab, Khalil, Ghabril, Marwan, Kniese, Christopher   +3 more
core   +2 more sources

Umbilical cord blood transplantation: Still growing and improving

Stem Cells Translational Medicine, 2021
Umbilical cord blood transplantation (UCBT) has been performed in the clinic for over 30 years. The biological and immunological characteristics of umbilical cord blood (UCB) have been re‐recognized in recent years.
Xiaoyu Zhu, Baolin Tang, Zimin Sun
doaj   +1 more source

Mesenchymal Stromal Cells for Transplant Tolerance

Frontiers in Immunology, 2019
In solid organ transplantation lifelong immunosuppression exposes transplant recipients to life-threatening complications, such as infections and malignancies, and to severe side effects. Cellular therapy with mesenchymal stromal cells (MSC) has recently
Manuel Alfredo Podestà, Manuel Alfredo Podestà, Giuseppe Remuzzi, Federica Casiraghi   +3 more
doaj   +1 more source

Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Organ Transplantation

Frontiers in Immunology, 2022
Organ transplantation is the most preferred treatment option for end-stage organ diseases; however, allograft rejection is the major hurdle in successful long-term transplant survival.
Saeedeh Salehi, Shima Afzali, Abbas Shahi, Abbas Shahi, Ali Akbar Amirzargar, Yaser Mansoori   +5 more
doaj   +1 more source

Transplantation in children [PDF]

, 1976
Kidney transplantation in very young children, less than 2 years of age, has usually failed, mainly because of difficulties maintaining these patients on hemodialysis long enough to permit retransplantation after loss of the original graft.
Charles W. Putnam, DeShazo, Kendrick A. Porter, Lilly, Lilly, Richard Weil, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Thomas E. Starzl   +15 more
core   +1 more source

Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation

Frontiers in Immunology, 2023
The critical balance between intended and adverse effects in allogeneic hematopoietic stem cell transplantation (alloHSCT) depends on the fate of individual donor T-cells.
Benedikt Obermayer, Luisa Keilholz, Luisa Keilholz, Thomas Conrad, Thomas Conrad, Marco Frentsch, Marco Frentsch, Igor-Wolfgang Blau, Lam Vuong, Lam Vuong, Stella Lesch, Stella Lesch, Kamran Movasshagi, Kamran Movasshagi, Carola Tietze-Stolley, Carola Tietze-Stolley, Lucie Loyal, Lucie Loyal, Lucie Loyal, Larissa Henze, Larissa Henze, Larissa Henze, Olaf Penack, Olaf Penack, Ulrik Stervbo, Ulrik Stervbo, Nina Babel, Nina Babel, Simon Haas, Simon Haas, Simon Haas, Dieter Beule, Lars Bullinger, Lars Bullinger, Lars Bullinger, Friedrich Wittenbecher, Friedrich Wittenbecher, Il-Kang Na, Il-Kang Na, Il-Kang Na, Il-Kang Na, Il-Kang Na   +41 more
doaj   +1 more source